| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TXG | Class A Common Stock | Options Exercise | $210K | +41.7K | +88.43% | $5.04* | 88.8K | Sep 1, 2021 | Direct | F1 |
| transaction | TXG | Class A Common Stock | Sale | -$183K | -1.05K | -1.18% | $174.39 | 87.7K | Sep 1, 2021 | Direct | F1, F2 |
| transaction | TXG | Class A Common Stock | Sale | -$479K | -2.73K | -3.11% | $175.69 | 85K | Sep 1, 2021 | Direct | F1, F3 |
| transaction | TXG | Class A Common Stock | Sale | -$1.33M | -7.53K | -8.86% | $176.65 | 77.5K | Sep 1, 2021 | Direct | F1, F4 |
| transaction | TXG | Class A Common Stock | Sale | -$3.76M | -21.1K | -27.29% | $177.72 | 56.3K | Sep 1, 2021 | Direct | F1, F5 |
| transaction | TXG | Class A Common Stock | Sale | -$1.53M | -8.59K | -15.24% | $178.56 | 47.7K | Sep 1, 2021 | Direct | F1, F6 |
| transaction | TXG | Class A Common Stock | Sale | -$113K | -628 | -1.32% | $179.20 | 47.1K | Sep 1, 2021 | Direct | F1, F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TXG | Stock Option (right to buy) | Options Exercise | $0 | -41.7K | -28.84% | $0.00 | 103K | Sep 1, 2021 | Class A Common Stock | 41.7K | $5.04 | Direct | F1, F8 |
| Id | Content |
|---|---|
| F1 | The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. |
| F2 | This transaction was executed in multiple trades at prices ranging from $174.14 to $175.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F3 | This transaction was executed in multiple trades at prices ranging from $175.14 to $176.135. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F4 | This transaction was executed in multiple trades at prices ranging from $176.14 to $177.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F5 | This transaction was executed in multiple trades at prices ranging from $177.14 to $178.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F6 | This transaction was executed in multiple trades at prices ranging from $178.14 to $179.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F7 | This transaction was executed in multiple trades at prices ranging from $179.14 to $179.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F8 | This option, originally for 175,000 shares, of which 72,218 shares have been exercised, vested as to one forty-eighth of the shares on October 1, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
Chief Scientific Officer and President